tirzepatide and kidney function Interplay of Chronic Disease the Effects of in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial Tirzepatide improves kidney outcomes in

Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2

Obesity and Infertility: A Metabolic Assessment Strategy to Improve Pregnancy Rate. PubMed Central (PMC) , 1 Mar

In this article, you'll discover: GLP-1 drugs may promote weight loss but often at the cost of muscle mass, which can slow metabolism over time

We encourage you to choose a medical weight-loss program that provides dietary and exercise support in addition to medication

It has been hypothesised, based largely on data from tirzepatide studies, that GIPR agonism may moderate some of the gastrointestinal side effects associated with GLP-1R stimulation